MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KAPA has $8,066K in assets. $5,575K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1655.72%
Cash Ratio
1386.82%
Assets Breakdown
    • Cash and cash equivalents
    • Vendor advances, gross
    • Less accumulated amortization
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Common stock, par value 0.001, 1...

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
5,575 3,034
Vendor advances, gross
3,271 -
Less accumulated amortization
2,214 -
Vendor advances, net
1,057 1,717
Prepaid expenses and other current assets
24 88
Total current assets
6,656 4,839
Deferred offering costs
1,308 1,692
Intangible assets, net
102 142
Total other assets
1,410 1,834
Total assets
8,066 6,673
Accounts payable and accrued expenses
402 676
Total current liabilities
402 676
Common stock, par value 0.001, 100,000,000 shares authorized 20,821,353 and 13,736,597 shares issued and outstanding, respectively
21 18
Additional paid-in capital
20,540 17,478
Accumulated deficit
-12,897 -11,499
Total shareholders equity
7,664 5,997
Total liabilities and shareholders equity
8,066 6,673
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Vendor advances, gross$3,271K Intangible assets, net$102K Deferred offering costs$1,308K Prepaid expenses andother current assets$24K Vendor advances, net$1,057K Cash and cashequivalents$5,575K Less accumulatedamortization$2,214K Total other assets$1,410K Total current assets$6,656K Total assets$8,066K Total liabilities andshareholders equity$8,066K Total shareholdersequity$7,664K Total currentliabilities$402K Accumulated deficit-$12,897K Additional paid-in capital$20,540K Accounts payable andaccrued expenses$402K Common stock, par value0.001, 100,000,000...$21K

Kairos Pharma, LTD. (KAPA)

Kairos Pharma, LTD. (KAPA)